Physician profile
Heather Smith
NPI 1356042642
$1,229.39
in general payments reported to CMS, 2019-2025
19 companies · $308 in 2025
The $308 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $291 · 2024: $630 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,133 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $96.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,133.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $96.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $224.27 | 2023-2025 | Gemtesa |
| Abbvie INC. | $159.32 | 2023-2025 | |
| Ferring Pharmaceuticals INC. | $140.50 | 2024-2025 | Adstiladrin |
| Urogen Pharma, INC. | $99.89 | 2023-2025 | Jelmyto |
| Tolmar, INC. | $89.75 | 2023-2025 | Jatenzo |
| Dentsply Ih Ab | $82.59 | 2023-2025 | Lofric, Lofric |
| 180 Medical, INC. | $57.65 | 2023-2025 | Gentlecath |
| Endo USA, INC. | $48.14 | 2024 | Xiaflex, Aveed |
| Progenics Pharmaceuticals, INC. | $46.59 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $45.99 | 2023-2024 | Aveed, Xiaflex |
| Pfizer INC. | $40.08 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $33.83 | 2024 | Keytruda |
| Ambu INC. | $28.52 | 2024 | |
| Coloplast Corp | $28.52 | 2024-2025 | |
| Janssen Biotech, INC. | $28.51 | 2024 | Erleada |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $28.05 | 2024 | |
| Myriad Genetic Laboratories, INC. | $18.17 | 2023 | Prolaris |
| Halozyme INC | $15.25 | 2023 | |
| Boston Scientific Corporation | $13.77 | 2025 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.